World Video | Defence | Foreign Affairs | Natural Events | Trade | NZ in World News | NZ National News Video | NZ Regional News | Search

 


1st Test of Focused Ultrasound to Destroy Breast Tumors

UVA Launches Nation’s 1st Test of Focused Ultrasound to Destroy Breast Tumors

Non-cancerous Fibroadenomas Affect Up to 25 Percent of Women


CHARLOTTESVILLE, Va., Aug. 25, 2014 – Expanding its pioneering work in the field of focused ultrasound, the University of Virginia Health System has launched the nation’s first clinical trial testing the technology’s potential to treat benign tumors of the breast known as fibroadenomas.

Fibroadenomas are the most common type of lump within the breast. They often appear in young women, occurring most frequently between the ages of 15 and 35. While fibroadenomas are harmless and non-cancerous, many women consider them bothersome and wish to have them removed. “Currently, the only way to make the lump go away is to do an operation,” explained David R. Brenin, MD, lead investigator of UVA’s trial. “You make an incision and remove the mass, but it leaves a scar. After the operation there is no lump, but the patient has a scar.”

Brenin and his colleagues are testing whether high-intensity focused ultrasound could offer a safe and effective alternative to surgery, one that would leave no scar. “The device is already approved for non-invasive surgery in Europe by their version of the FDA, but this is the first time it has been tested in the U.S. for treatment of fibroadenomas, or for any type of breast tumor,” Brenin said.

About Focused Ultrasound
The high-intensity focused ultrasound, in essence, concentrates sound waves to generate heat, much like a magnifying glass can focus light. By focusing those sound waves on fibroadenomas, the UVA researchers can make them go away without needing to cut into the body. “The great benefit of this approach is that we have real-time visualization, so we can watch as we perform the procedure to target exactly where we want to target,” said UVA researcher Carrie Rochman, MD. The trial represents an important collaboration of her department, radiology, and Brenin’s department, surgery.

UVA expects to test the safety and efficacy of the procedure in 20 trial participants within the next year. “This is the first step of evaluating the device to treat tumors of the breast non-surgically,” Brenin said. “Ultimately, the goal is not just to treat fibroadenomas but to treat other, malignant breast tumors.

Cutting-Edge Research
The new trial expands UVA’s groundbreaking research into the potential applications of the scalpel-free focused ultrasound technology. UVA neurosurgeonJeffrey Elias, MD, first tested focused ultrasound in 15 volunteers with essential tremor, a common movement disorder. All 15 reported “significant improvement” in their hand tremor and in their quality of life. Elias has since launched a larger, international trial and is also evaluating the technology for its potential to reduce shaking associated with Parkinson’s disease.

FOR POTENTIAL TRIAL PARTICIPANTS:
People interested in being considered as volunteers for the fibroadenoma trial should contact Katie Rea, RN, clinical research coordinator, at 434.243.0315. The trial is IRB No. 17277.

ENDS

© Scoop Media

 
 
 
 
 
World Headlines

 

Peace Deal ‘first Step’ In Resolving South Sudan Crisis

Children at a protection of civilians site in Juba, South Sudan, run by the UN Mission, perform at a special cultural event in March 2015. UN Photo/JC McIlwaine More>>

Yemen: Killing Or Maiming An Average Of Eight Children A Day

Killing or maiming an average of eight children a day, ‘brutal’ Yemen conflict must end – UNICEF More>>

Changing Habits/behaviours Key To Overcome Vaccine Hesitancy

Vaccine hesitancy can be caused by factors such as negative beliefs based on myths, misinformation. Fear of needles can be a factor for refusal. Photo: PAHO/WHO More>>

Burundi: Ban Condemns Assassination Of Senior Army Officer

Refugees from Burundi in South Kivu, Democratic Republic of the Congo (DRC). Photo: OCHA/Naomi Frerotte United Nations Secretary-General Ban Ki-moon has condemned the assassination Burundi’s former Army Chief of Staff, Colonel Jean Bikomagu, who ... More>>

Deadly Industrial Explosions In Northern China

United Nations Secretary-General Ban Ki-moon has been deeply saddened to learn of the loss of life and the injuries to scores of people as a result of deadly explosions in Tianjin, China. More>>

UN Urges Action To Tackle Deepening Refugee Crisis In Greece

A group of Syrian refugees arrive on the island of Lesbos after travelling in an inflatable raft from Turkey, near Skala Sykaminias, Greece. Photo: UNHCR/A. McConnell More>>

Probe Into Those Responsible For Chemical Weapons In Syria

The US Vessel Cape Ray, on which all 581 metric tonnes of a precursor chemical for sarin gas were removed from Syria and safely destroyed as the ship sailed in international waters in 2014. Photo: US Dept. of Transportation More>>

Myanmar Election: UNICEF Urges Prioritisation Of Children

With 99 days to go before Myanmar elections, UNICEF urges candidates make children the clear winner More>>

Liberia Thousands Of Unregistered Children Born During Ebola Crisis

Thousands of unregistered children born in Liberia during Ebola crisis at risk of exploitation – UNICEF More>>

UN Refugee Agency Envoy Angelina Jolie Visits Myanmar

UNHCR Special Envoy Angelina Jolie Pitt (left) in Myitkyina township, Kachin State, Myanmar, meeting with some of the 100,000 displaced people who currently live there. Photo: UNHCR/T.Stoddart More>>

Get More From Scoop

 
 
 
 
 
World
Search Scoop  
 
 
Powered by Vodafone
NZ independent news